Monks Investment Trust Plc (MNKS)
Category Global Large-Cap Growth Equity
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
1,250.00p
Buy
1,258.00p
-4.00p (-0.32%)
Discount/Premium
-10.34%
Estimated NAV
1,396.459p
Prices updated at 20 Dec 2024, 16:50 GMT
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The objective of the company is to invest globally to achieve capital growth. This takes priority over income and dividends. The company seeks to meet it objective by investing principally in a portfolio of global quoted equities.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- Risk
- News & dates
- Trust info
- Director info
Company name
Baillie Gifford & Co Limited.
Legal structure
Closed Ended Investment Company
Domicile
United Kingdom
Fiscal year end
30 Apr 2025
Launch date
06 Feb 1929
Lead manager
Spencer Adair
Lead manager start date
27 Mar 2015
Lead fund manager biography
Spencer joined Baillie Gifford in 2000 and is an Investment Manager in the Global Alpha Team. He became a Partner in 2013 and has also spent time working in the Fixed Income, Japanese, European and UK Equity Teams. Spencer graduated BSc in Medicine from the University of St Andrews in 1997, followed by two years of clinical training in Edinburgh.
Head office
Calton Square
1 Greenside Row
Edinburgh
United Kingdom
EH1 3AN